Product Reports Resources Pricing Login Book a demo

Constellation Pharmaceuticals

Biotech & Life Sciences · Cambridge, United States · Founded 2008 · IPO 2018

Constellation Pharmaceuticals operates in the biopharmaceutical industry, focusing on the development of innovative therapies targeting epigenetic regulators to treat cancer. The company leverages its integrated epigenetics platform to understand the biology of gene expression regulation and develop small molecule product candidates that selectively modulate the activity of these regulators. Constellation Pharmaceuticals primarily serves patients with cancer, aiming to provide new treatment options through its clinical development programs, which are supported by novel biomarker strategies. The company's business model revolves around research and development, clinical trials, and eventual commercialization of its therapeutic candidates. Revenue is generated through partnerships, licensing agreements, and potential future sales of approved therapies. Keywords: epigenetics, cancer therapy, gene expression, small molecules, clinical trials, biomarkers, biopharmaceutical, oncology, drug development, innovative therapies.

Valuation $1.70B
Total funding $100–500M
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue

Investors

16 investors on Constellation Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage
Venrock
Third Rock Ventures
The Column Group
Altitude Life Science Ventures
SR One
Series B+ 11 investors entered at this stage
Genentech
Solon Mack Capital
Fidelity Investments
Hillhouse Capital
Sirona Capital
Avoro Capital Advisors
Deerfield
Cormorant Asset Management
Casdin Capital
OrbiMed
Venrock Healthcare Capital Partners

Global footprint

Where Constellation Pharmaceuticals has talent and traffic

Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown

Talent graph

The shape of Constellation Pharmaceuticals's talent

Dealroom maps Constellation Pharmaceuticals's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

21 team members profilednamed & role-tagged by Dealroom
48 employeestotal headcount
7 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Constellation Pharmaceuticals's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$107M patent portfolio · 66 active families

Estimated portfolio value
$107M
6.3% of market cap · 53.8× smaller than top peer Ablynx ($5.8B)
66 active patent families
Where Constellation Pharmaceuticals innovates BromodomainCancer researchDiseaseEnzymeMedicinal chemistry

Where Constellation Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Constellation Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Constellation Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Constellation Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Constellation Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles